Last updated: January 24, 2024
Sponsor: Second Hospital of Shanxi Medical University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hip Replacement
Treatment
total hip replacement
Clinical Study ID
NCT03120312
ZGuo
Ages 60-89 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- ASA Ⅱ-Ⅲ,elective operation patients,
- NO other severe complication history
Exclusion
Exclusion Criteria:
- Having severe comorbidity
- not for the first time of joint replacement
- Suffered from neurologic disorder or impaired mental state
Study Design
Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: total hip replacement
Phase:
Study Start date:
October 30, 2020
Estimated Completion Date:
January 31, 2024
Study Description
Connect with a study center
Zheng Guo
Taiyuan, Shanxi 030001
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.